CSV News Alert Carriage Services (CSV) 20.86 12/25/2014 16:5

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Carriage Services (CSV) 20.86 $CSV

Archer Daniels (ADM) Growth Plans Gain Solid Momentum - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 5:10PM CST
Archer Daniels (ADM) announced a host of capital allocation strategies yesterday and also outlined the key areas where it plans to focus to control its operations better.
WDFC: 84.59 (-0.01), CSV: 20.86 (+0.05), ADM: 53.11 (-0.06), PPC: 34.01 (+0.49)

New Media Investment Group (NEWM) in Focus: Stock Rises 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 8:18AM CST
New Media Investment Group Inc. (NEWM) was a big mover last session, as the company saw its shares rise by over 6% on the day.
JOBS: 36.03 (+0.03), CSV: 20.86 (+0.05), ARMK: 30.57 (+0.07), NEWM: 24.15 (+0.54)

Long-Term Investing In The Death Care Industry Through Carriage Services
Mitchell Warren - at Seeking Alpha - Wed Nov 26, 9:18AM CST

CSV: 20.86 (+0.05), RJF: 57.73 (-0.02)

Inter Parfums (IPAR) Crumbles: Stock Falls by 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 7:45AM CST
Inter Parfums has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
JOBS: 36.03 (+0.03), CSV: 20.86 (+0.05), ARMK: 30.57 (+0.07), IPAR: 27.84 (-0.60)

Summer Infant (SUMR) in Focus: Stock Adds 6.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:11AM CST
Summer Infant, Inc. (SUMR) was a big mover last session, as the company saw its shares rise nearly 7% on the day.
CSV: 20.86 (+0.05), NTRI: 19.66 (+0.02), SUMR: 3.10 (+0.06), SPB: 97.15 (-0.49)

Farmer Brothers (FARM) in Focus: Stock Falls 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:31AM CST
Farmer Brothers saw a big move last session, as the company’s shares fell by nearly 7% on the day.
CSV: 20.86 (+0.05), PPC: 34.01 (+0.49), CVGW: 47.77 (+0.17), FARM: 30.06 (-0.16)

Weakness Seen in Nu Skin Enterprises (NUS): Stock Tumbles 13.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 7:30AM CST
Nu Skin Enterprises saw a big move last session, as the company’s shares fell by over 13% on the day.
HELE: 64.04 (+0.16), CSV: 20.86 (+0.05), NUS: 45.27 (+0.78), PPC: 34.01 (+0.49)

Carriage Services' (CSV) CEO Mel Payne on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 31, 5:16PM CDT

CSV: 20.86 (+0.05)

Carriage Services posts 3Q profit
Automated Insights - Wed Oct 29, 6:24PM CDT
HOUSTON (AP) _ Carriage Services Inc. (CSV) on Wednesday reported earnings of $5 million in its third quarter.
CSV: 20.86 (+0.05)

Carriage beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:58PM CDT

CSV: 20.86 (+0.05)

Carriage Services Announces Record Results For Third Quarter 2014, Raises Rolling Four Quarter Outlook
PR Newswire - Wed Oct 29, 3:01PM CDT
Carriage Services, Inc. (NYSE: CSV) today announced record results for the quarter ended September 30, 2014.
CSV: 20.86 (+0.05)

Carriage Services announces dividend of USD0.0205 per share for quarter
M2 - Tue Oct 28, 4:31AM CDT
The board of directors of a provider of Carriage Services Inc (NYSE:CSV), a US provider of death-care services and merchandise, authorised a quarterly dividend of USD0.0205 per share on the company's common stock, it disclosed on Monday.
CSV: 20.86 (+0.05)

Carriage Services declares $0.025 dividend
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 3:37PM CDT

CSV: 20.86 (+0.05)

Carriage Services Declares Quarterly Cash Dividend
PR Newswire - Mon Oct 27, 3:02PM CDT
Carriage Services, Inc. (NYSE: CSV) today announced that its Board of Directors on October 27, 2014 declared the quarterly dividend of 2.5 cents per share payable on December 1, 2014 to common share record holders as of November 13, 2014. The Company also has a dividend reinvestment program that is available so that shareholders may elect to reinvest their dividends into additional shares of the Company's common stock.
CSV: 20.86 (+0.05)

Carriage Services Announces Third Quarter Earnings Release and Conference Call Schedule
PR Newswire - Wed Oct 15, 3:48PM CDT
Carriage Services, Inc. (NYSE: CSV) today announced plans to release 2014 third quarter results on Wednesday, October 29, 2014 after the market closes. In conjunction with the release, Carriage Services has scheduled a conference call, which will be broadcast live over the Internet on Thursday, October 30, 2014 at 9:30 a.m. central time.
CSV: 20.86 (+0.05)

Weakness Seen in Scholastic (SCHL): Stock Falls 5.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 7:38AM CDT
Scholastic Corporation (SCHL) fell nearly 6% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down over 9% in the past one-month time frame.
CSV: 20.86 (+0.05), SCHL: 35.39 (+0.07), PPC: 34.01 (+0.49), ANFI: 12.75 (+2.95)

Tumi Holdings (TUMI) in Focus: Stock Falls 5.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 7:35AM CDT
Shares of Tumi Holdings (TUMI) fell by nearly 6% on the day. This continues the recent trend for TUMI, as the stock is now down nearly 11% since Aug 19. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue.
CSV: 20.86 (+0.05), ARMK: 30.57 (+0.07), FDP: 32.43 (+0.33), TUMI: 23.54 (+0.14)

Weakness Seen in Helen of Troy (HELE): Stock Slumps by 10.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 7:52AM CDT
Shares of Helen of Troy fell over 10% last session and witnessed flat revision in current year estimates in the past few weeks suggest a close watch of the firm in the near future.
HELE: 64.04 (+0.16), CSV: 20.86 (+0.05), ARMK: 30.57 (+0.07), FDP: 32.43 (+0.33)

Should You Get Rid of Elizabeth Arden (RDEN) Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 7:39AM CDT
Elizabeth Arden one such stock that can be considered to drop as it has witnessed a significant price decline and has seen negative earnings estimate revisions
CSV: 20.86 (+0.05), ARMK: 30.57 (+0.07), RDEN: 20.56 (-0.24)

Should You Get Rid of Tribune Media (TRBAA) Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 7:54AM CDT
Tribune Media is one such stock that can be considered to drop as it has witnessed a significant price decline and has seen negative earnings estimate revisions
CSV: 20.86 (+0.05), ARMK: 30.57 (+0.07), FDP: 32.43 (+0.33)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading